Get started
Author

Guoxing Luo

Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo
2021 · Siyuan Yu, Han Yang, et al. · Nature Communications · 115
PDF
Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine
2018 · Yijian Li, Miaoge Xue, et al. · Vaccine · 33
The distinct impact of maternal antibodies on the immunogenicity of live and recombinant rotavirus vaccines
2019 · Han Yang, Guoxing Luo, et al. · Vaccine · 13
Effects of Site-Mutations Within the 22 kDa No-Core Fragment of the Vip3Aa11 Insecticidal Toxin of Bacillus thuringiensis
2017 · Ming Liu, Rongmei Liu, et al. · Current Microbiology · 13
Bivalent rotavirus VP4∗ stimulates protective antibodies against common genotypes of human rotaviruses
2022 · Guoxing Luo, Yuanjun Zeng, et al. · iScience · 12
Effect of C-terminus site-directed mutations on the toxicity and sensitivity ofBacillus thuringiensisVip3Aa11 protein against three lepidopteran pests
2017 · Baoyan Chi, Guoxing Luo, et al. · Biocontrol Science and Technology · 12
VP8 Mosaic Nanoparticles Elicit Cross-Neutralizing Immune Responses and Provide Protection Against Heterotypic Rotavirus Challenge in Mice
2024 · Feibo Song, Yuanjun Zeng, et al. · ACS Nano · 10
Generation and characterization of mouse monoclonal antibodies against the VP4 protein of group A human rotaviruses
2022 · Yuanjun Zeng, Feibo Song, et al. · Antiviral Research · 10
Establishment of Sandwich ELISA for Quality Control in Rotavirus Vaccine Production
2022 · Cao Li, Guoxing Luo, et al. · Vaccines · 9
PDF
A single residue switch mediates the broad neutralization of Rotaviruses
2025 · Yang Huang, Feibo Song, et al. · Nature Communications · 7
PDF
Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · Haifeng Pan, Siyuan Yu, et al. · Cancer Immunology Research · 5
Wa-VP4* as a candidate rotavirus vaccine induced homologous and heterologous virus neutralizing antibody responses in mice, pigs, and cynomolgus monkeys
2024 · Guoxing Luo, Yuanjun Zeng, et al. · Vaccine · 4
Truncated rotavirus VP4 proteins induce stronger protective immunity compared to P2 - VP8 in animal models
2025 · Yaling Chen, Guoxing Luo, et al. · Antiviral Research · 2
Author response for "Sustained-release microneedles for drug delivery: advances and prospects"
2026 · Penghui He, Chunting He, et al. · Publons reviews and discussion
Author response for "Sustained-release microneedles for drug delivery: advances and prospects"
2026 · Penghui He, Chunting He, et al. · Publons reviews and discussion
Rapid development of a robust cultivation process for subunit rotavirus vaccine antigen expression in Escherichia coli with the quality by design approach
2026 · Daning Wang, Minming Chen, et al. · Bioprocess and Biosystems Engineering
PDF
Sustained-release microneedles for drug delivery: advances and prospects
2026 · Penghui He, Chunting He, et al. · Journal of Materials Chemistry B
Supplementary Fig. S15 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · Haifeng Pan, Siyuan Yu, et al.
Supplementary Fig. S14 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · Haifeng Pan, Siyuan Yu, et al.
Supplementary Fig. S6 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · Haifeng Pan, Siyuan Yu, et al.
Data from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · Haifeng Pan, Siyuan Yu, et al.
Supplementary Fig. S5 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · Haifeng Pan, Siyuan Yu, et al.
Supplementary Fig. S23 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · Haifeng Pan, Siyuan Yu, et al.
Supplementary Fig. S3 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · Haifeng Pan, Siyuan Yu, et al.
Supplementary Fig. S20 from Orchestrated Codelivery of Peptide Antigen and Adjuvant to Antigen-Presenting Cells by Using an Engineered Chimeric Peptide Enhances Antitumor T-Cell Immunity
2024 · Haifeng Pan, Siyuan Yu, et al.
Works count: 47
Citation count: 245
H-index: 9
I10-index: 8
Year
Topic
Type